Silvant Capital Management’s Chemed CHE Stock Holding History

Silvant Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,493	Closed	-$652K	–	304
2022 Q3	$652K	Hold	1,493	–	–	0.04%	144
2022 Q2	$701K	Hold	1,493	–	–	0.17%	88
2022 Q1	$756K	Hold	1,493	–	–	0.14%	100
2021 Q4	$790K	Sell	1,493 -96	-6%	-$46.1K	0.14%	106
2021 Q3	$739K	Hold	1,589	–	–	0.13%	108
2021 Q2	$754K	Hold	1,589	–	–	0.12%	107
2021 Q1	$731K	Hold	1,589	–	–	0.12%	106
2020 Q4	$846K	Hold	1,589	–	–	0.14%	101
2020 Q3	$763K	Hold	1,589	–	–	0.14%	99
2020 Q2	$717K	Hold	1,589	–	–	0.13%	100
2020 Q1	$688K	Hold	1,589	–	–	0.15%	96
2019 Q4	$698K	Hold	1,589	–	–	0.13%	101
2019 Q3	$664K	Hold	1,589	–	–	0.13%	101
2019 Q2	$573K	Hold	1,589	–	–	0.1%	106
2019 Q1	$509K	Hold	1,589	–	–	0.09%	112
2018 Q4	$450K	Hold	1,589	–	–	0.09%	114
2018 Q3	$508K	Hold	1,589	–	–	0.06%	122
2018 Q2	$511K	Hold	1,589	–	–	0.06%	118
2018 Q1	$434K	Buy	+1,589	New	+$421K	0.06%	129

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Silvant Capital Management's CHE Position: Q4 2022 in Review

Silvant Capital Management sold out of Chemed (CHE) in Q4 2022, closing a stake of 1,493 shares — an estimated $652K sold.

Silvant Capital Management first reported a position in CHE in Q1 2018 and held it in 19 quarters. The position peaked at $846K in Q4 2020. 442 funds tracked by Wall St. Rank hold CHE as of Q4 2022.

Silvant Capital Management reported no remaining Chemed position as of Q4 2022 after selling out during the quarter.
Silvant Capital Management sold 1,493 Chemed shares in Q4 2022, an estimated $652K.
Silvant Capital Management first reported a position in Chemed in Q1 2018 and held it in 19 quarters.
Silvant Capital Management's Chemed position peaked at $846K in Q4 2020.
442 funds tracked by Wall St. Rank held Chemed as of Q4 2022.

Based on Silvant Capital Management's 13F filing for Q4 2022, filed 23 Jan 2023.